Patton and her entire family have suffered from the Fosamax and Boniva prescriptions she has taken since 2001. Patton took Fosamax from 2001 to 2006, and took Boniva from 2006 to 2010. Doctors prescribed Fosamax and Boniva, both bisphosphonate drugs, to slow bone loss and combat Patton’s osteoporosis.

However, long term use of these drugs has actually been found to cause brittle bones and to increase the risk of atypical bone fractures. On December 10, 2010, Patton suffered a subtrochanteric femoral fracture while walking up steps. This aptypical femur fracture has been devasting for Patton and her family. Patton noted, “My husband now does a lot of the work I used to do. The accident changed a good part of my life; it put a lot of extra burden on my family.”

Lieff Cabraser attorney Kent Klaudt announced that Reba Patton and her husband Patrick Patton have filed a lawsuit against Fosamax manufacturer Merck&Co., and against Boniva manufacturer GlaxoSmithKine, LLC. Klaudt said, “Merck and GlaxoSmithKline, as alleged in the complaint, concealed and continue to conceal their knowledge of bisphosphonates’ lack of long-term benefits and dangers to Mrs. Patton and other patients.”

To learn more about Fosamax, Boniva and other bisphosphonate drugs, as well as victims’ rights, visit our Bone Drugs and Femur Fractures information page.

Transvaginal mesh was approved as a moderate risk device under the FDA’s controversial 510(k) process. The FDA’s 510(k) process allows for a medical device to be approved for market without clinical data if it is deemed “substantially equivalent” to products already on the market. This “substantially equivalent” approval condition has been criticized as overly lax and responsible for public health nightmares such as DePuy’s recalled ASR hip implant.

Transvaginal mesh failures were cited in the U.S. Institute of Medicine’s July review of the FDA’s medical device approval and their recommendation that the process be replaced with a stricter system. Opponents of transvaginal mesh allege that the mesh products, currently classified as moderate risk devices, expose patients to higher risks than non-mesh products, and ask that transvaginal mesh be recalled and reclassified as a high risk device.

Previously reported in Bloomberg, the FDA issued a transvaginal mesh safety warning in July 2011, stating that it has received “1,503 reports of complication associated with the material from January 2008 to December 2010.” It is in response to these widespread reports of complications that the FDA is considering a change in risk classification.

Bayer is the leading manufacturer of birth control pills, and their development of a new contraceptive pill comes at a time when Bayer is still dealing with the fall out from alleged serious side effects from its previous birth control drug Yaz.

Across the U.S., almost 3,000 women are suing Bayer alleging serious injuries related to the use of the drug. Side effects may include blood clots, deep vein thrombosis, strokes, heart attacks, gall bladder damage, and kidney problems. In certain cases, women have died suddenly. Learn more about dangerous Yaz side effects and Yaz lawsuits.

Yaz side effects and Yaz lawsuits

Paxil, Paxil Oral Suspension, and Paxil-CR are trade names of the drug Paroxetine, which is a member of a class of drugs known as “selective serotonin reuptake inhibitors” (SSRIs). A 2005 study based on 3,500 pregnant women, linked Paxil to twice as many birth defects compared to other antidepressants when taken during the first three months of pregnancy.

The birth defects identified in the study included congenital defects, heart defects and persistent pulmonary hypertension of the newborn (PPHN), a potentially fatal disease.

If your child was born with birth defects and you were prescribed Paxil or other antidepressant drugs while pregnant, please contact our law firm to learn about your rights for no charge or obligation.

The decision to update the labels came after two studies that were commissioned by Bayer showed that the risk of Yaz and Yasmin was comparable to that of other oral contraceptives on the market, according to press reports.

Click here to learn more about the risks associated with Yaz and Yasmin.

In a report by the CBS affiliate TV station in Nashville, Tennessee, Traci Mayfield spoke of her love for her 20-year old daughter Leah, “We were more than mother/daughter, we were best friends. She blossomed into a beautiful young lady [in college].”

Leah and Traci Mayfield

Traci Mayfield has filed a lawsuit against Bayer, the manufacturer of Yaz, for death of her daughter, and is warning others of the dangers of Yaz.  (Ms. Mayfield is represented by Lieff Cabraser Heimann & Bernstein, LLP). Watch the news report.

If you or a loved one have been injured or died as a result of taking Yaz or Yasmin, please visit Lieff Cabraser’s Yaz/Yasmin legal information page or call us toll-free at 1-800-541-7358. Our personal injury attorneys and legal nurse consultants will promptly review your case for no charge or obligation on your part.

Ms. Fleishman also discusses the risks of these drugs in a YouTube video entitled:  Yaz | Yasmin Drug Side Effects & Dangers Explained

If you or a loved one have been injured or died as a result of taking Yaz or Yasmin, please visit Lieff Cabraser online at http://lieffcabraser.com/personal-injury-mass-torts/case/249/yasmin-yaz-ocella-lawsuit or call us toll-free at 1-800-541-7358. Our personal injury attorneys and legal nurse consultants will promptly review your case for no charge or obligation on your part.

On Friday, the jury in Kendall v. Wyeth awarded more than $6 million in compensatory damages to plaintiffs Donna Kendall and John Kendall Jr., their attorneys said. In the punitive damages part of the case decided Monday, the jury awarded $16 million against Wyeth, which is now owned by Pfizer, and $12 million against Pharmacia & Upjohn, which also is now owned by Pfizer. The total verdict adds up to more than $34 million.

Read the full article on law.com.

“While prescribed Yaz, my daughter developed several pulmonary emboli, which obstructed her pulmonary artery and caused her to suffer cardiac arrest. My baby was dead for almost three minutes,” stated Dana Kraus. “She was in excellent health prior to taking Yaz. This was a terrifying experience. We almost lost her. We were so lucky. The doctors at Children’s Hospital of Pittsburgh were able to save her life.” Pulmonary emboli are blood clots in the lungs that can lead to abnormally low blood pressure and sudden death.

“As alleged in the Complaint, Yaz is a dangerous prescription drug sold without adequate warnings about the risks of serious and fatal injuries,” stated attorney Wendy R. Fleishman. “Bayer failed to warn doctors and patients that Yaz poses a greater risk of serious side than previous generations of oral contraceptives.”

Atkinson, age 33 of Rock Hill, South Carolina, charges that Yaz is a dangerous prescription drug sold without adequate warnings about the risk of serious injuries. Atkinson further alleges that Bayer improperly advertised and over-promoted Yaz for uses such as treating acne, knowing that the risks of such use outweighed any benefits Yaz may have for acne sufferers.

Learn more….